Safety of hepatic resection for hepatocellular carcinoma in obese patients with cirrhosis
Shogo Tanaka(Osaka Metropolitan University), Jiro Fujimoto(Harvard University), Seikan Hai(Hyogo Medical University), Tadamichi Hirano(Hyogo Medical University), Ikuo Nakamura(Hyogo Medical University), Yuji Iimuro(Yamanashi Prefectural Central Hospital), Kazuhiro Suzumura(Hyogo Medical University), Yuichi Kondo(Hyogo Medical University)
Cited by 26
Related Papers
Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors
|Oncogene|1999|693
Hepatocyte growth factor gene therapy of liver cirrhosis in rats
|Nature Medicine|1999|588
Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system
|International Immunology|2008|480
NFkappaB prevents apoptosis and liver dysfunction during liver regeneration.
|Journal of Clinical Investigation|1998|454